×
Bayer Other Income 2012-2025 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Bayer other income for the twelve months ending December 31, 2025 was
$0M
, a
0% increase
year-over-year.
Bayer annual other income for 2025 was
$0B
, a
0% decline
from 2024.
Bayer annual other income for 2024 was
$0B
, a
0% decline
from 2023.
Bayer annual other income for 2023 was
$0B
, a
0% decline
from 2022.
View More
Bayer Other Income 2012-2025 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Bayer annual other income for 2025 was
$0B
, a
0% decline
from 2024.
Bayer annual other income for 2024 was
$0B
, a
0% decline
from 2023.
Bayer annual other income for 2023 was
$0B
, a
0% decline
from 2022.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
AbbVie (ABBV)
$367.7B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Innoviva (INVA)
$1.8B